Bozeman, MT, United States
Bozeman, MT, United States

Time filter

Source Type

The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. Proton therapy is an advanced form of radiation therapy that uses high-energy proton beam rather than conventional radiotherapy to irradiate a tumor. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. The number of proton therapy centers is increasing in United States. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-Billion-dollar potential market. The numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are huge. IBA dominates the proton therapy market. However, other players like Varian, Mevion, Hitachi etc. have also started to make their presence felt in the market. The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment. The number of proton therapy centers in United States is anticipated to increase year on year, which in turn, will result in more clinical research, better clinician understanding and greater patient awareness of its benefits-which will help drive the further growth. 1. Executive Summary 2. United States Proton Therapy Market Analysis 3. United States - List of Proton Therapy Centers, Start of Treatment, Patient Treated 4. United States Proton Therapy - Company Analysis 5. United States - Number of Patients Treated at Proton Therapy Centers 6. Current Radiation Therapies 7. Components of a Standard Proton Therapy Center 8. Proton Therapy - Driving Factors 9. Proton Therapy - Challenges For more information about this report visit http://www.researchandmarkets.com/research/djc5sx/united_states To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/united-states-proton-therapy-market-actual--potential-patients-treated-list-of-proton-therapy-centers-and-forecast-to-2022---research-and-markets-300449424.html


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "China Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022" report to their offering. China Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. Cancer incidence and mortality have been increasing in China, making cancer the leading cause of death since 2010 and a major public health problem in the country. With an increasing incidence of cancer, there is a definite need for novel, cutting edge, treatment methods, such as, Proton Therapy. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients. There are currently two operational proton therapy centers in China. IBA has one operational proton therapy center in China while 4 more centers are in development phase. For more information about this report visit http://www.researchandmarkets.com/research/xv64gh/china_proton


Dublin, April 25, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.The report also offers separate analysis for Proton Therapy Systems market at global and regional level. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Thousand by the following Product Segments: The report profiles 45 companies including many key and niche players such as: 13. GLOBAL MARKET PERSPECTIVE For more information about this report visit http://www.researchandmarkets.com/research/hq5wdp/radiation_therapy


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Proton Therapy Market in Russia & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report to their offering. Untapped Market of Proton Therapy in Russia Would Be More Than US$ 3 Billion During Forecast Period Proton Therapy Market in Russia & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers provides a detailed assessment of the Proton Therapy Market in Russia. In this report we have studied the market in two parts: a) Actual Market and b) Untapped Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. IBA, the world's leading provider of proton therapy solutions for the treatment of cancer, has started installation of the Cyclone® 230 in 2016 for a new proton therapy center. The acceptance of the first treatment room is planned for the end of 2017. The proton therapy center in Dimitrovgrad will be IBA's first in the Russian Federation and is expected to treat up to 1,200 patients per year according to IBA. For more information about this report visit http://www.researchandmarkets.com/research/t7x2xj/proton_therapy


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report also offers separate analysis for Proton Therapy Systems market at global and regional level. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Thousand by the following Product Segments: The report profiles 45 companies including many key and niche players such as: For more information about this report visit http://www.researchandmarkets.com/research/kp88m2/radiation_therapy


News Article | May 3, 2017
Site: www.businesswire.com

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "South Korea Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022" report to their offering. South Korea Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. South Korea proton therapy market is anticipated to almost three-fold during the period 2016 - 2022. The number of patients treated with Proton Therapy in South Korea is very low whereas; the potential candidates for proton therapy are huge. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients. For more information about this report visit http://www.researchandmarkets.com/research/5hbpr8/south_korea


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Proton Therapy Market & Forecast (12 Countries Market Data), Patients Treated at Proton Therapy Centers, Reimbursement Policies" report to their offering. Global Proton Therapy Market potential is more than US$ 50 Billion in 2016. The proton therapy market is expected to grow with double digit CAGR in future. United States dominates the Proton Therapy Market globally, but it is losing its proton therapy market share year on year. Japan has the second highest proton therapy market share worldwide, but its proton therapy market is increasing year on year. Europe proton therapy market possesses a potential of more than US$ 10 Billion. In the case of Europe, France used to have the biggest proton therapy market share for the year 2009. But by the end of year 2012, Germany dethroned France from its peak place and took its spot. However as per our research United Kingdom proton therapy market will remove Germany proton therapy market form top position in future. Russia will be the one country which will be interesting to watch as it will increase its market share thrice in a span of 4 years. Asia proton therapy market is forecasted to grow with 18 percent CAGR. Proton therapy market is dominated by Japan, but China proton therapy market share is rising rapidly. Korea is also increasing its proton therapy market year on year. Globally close to 60 proton therapy centers were operational in 2016 and slightly less than 50 proton therapy centers is likely come in near future. Rising cancer incidence worldwide is the major key driver to boost proton therapy market. For more information about this report visit http://www.researchandmarkets.com/research/rqmcw2/global_proton


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Asia Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022" report to their offering. The report titled Asia Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. Asia proton therapy market is anticipated to almost three-fold during the period 2016 - 2022. The number of proton therapy centers is continuously increasing in Asia. Still, it is believed that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-Billion-dollar potential market. The number of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are huge. - Asia accounts for around 60% of the world population and half the global burden of cancer. - Mitsubishi is the leading player in proton therapy market in Japan. However, other players like IBA, Hitachi, Sumitomo etc. have also started to make their presence felt in the market. - South Korea is the second largest market for proton therapy in Asia. - China has the huge market opportunity for proton therapy treatment owing to large population base of cancer patients. - IBA has one operational proton therapy center in China while 4 more centers are in development phase. - In India, 2 proton therapy centers are under development phase and are scheduled to open in 2018 and 2019. For more information about this report visit http://www.researchandmarkets.com/research/kvbr5g/asia_proton


Farace P.,Proton Therapy
Physics in Medicine and Biology | Year: 2014

A two-steps procedure is presented to convert dual-energy CT data to stopping power ratio (SPR), relative to water. In the first step the relative electron density (RED) is calculated from dual-energy CT-numbers by means of a bi-linear relationship: RED = a HUscH + b HUscL + c, where HUscH and HUscL are scaled units (HUsc = HU + 1000) acquired at high and low energy respectively, and the three parameters a, b and c has to be determined for each CT scanner. In the second step the RED values were converted into SPR by means of published poly-line functions, which are invariant as they do not depend on a specific CT scanner. The comparison with other methods provides encouraging results, with residual SPR error on human tissue within 1%. The distinctive features of the proposed method are its simplicity and the generality of the conversion functions. © 2014 Institute of Physics and Engineering in Medicine.


Patent
Proton Therapy | Date: 2013-03-27

Provided is a device for multi-portal irradiation of particle beams which makes it possible to carry out multi-portal irradiation by remote operation without an operator having to enter an irradiation room. This device for remotely multi-portal irradiation of particle beams includes an irradiation room and a control room. The irradiation room comprises an irradiation device for emitting a particle beam at an irradiation target, an irradiation control device for controlling the position and direction of the irradiation device, and a support stand for supporting the irradiation target. The control room, in turn, includes a control device and a remote operation controller. The control device controls the position and direction of the irradiation device by controlling the irradiation control device.

Loading Proton Therapy collaborators
Loading Proton Therapy collaborators